Artificial intelligence, platelets and aspirin

Published: 15 March 2024
Abstract Views: 82
PDF: 61
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


An inspiring and timely review by Paolo Gresele, published in Bleeding, Thrombosis and Vascular Biology, at the end of last year, fascinated me through the description of applications of artificial intelligence in the field of hemostasis and thrombosis, examining its advantages, drawbacks and future perspectives [...]



PlumX Metrics


Download data is not yet available.



​Gresele P. Artificial intelligence and machine learning in hemostasis and thrombosis. Bleeding, Thrombosis and Vascular Biology 2023;2:105. DOI:
​Ganjavi C, Eppler MB, Pekcan A, et al. Publishers' and journals' instructions to authors on use of generative artificial intelligence in academic and scientific publishing: bibliometric analysis. BMJ 2024;384:e077192. DOI:
​Prillaman M. Is ChatGPT making scientists hyper-productive? The highs and lows of using AI. Nature. 2024;627:16-7. DOI:
​Dauerman HL, Turco JV, Fuster V. Artificial Intelligence, Bob Dylan, and Cardiovascular Scholarship. J Am Coll Cardiol. 2023;82:961-3. DOI:

How to Cite

de Gaetano, G. (2024). Artificial intelligence, platelets and aspirin. Bleeding, Thrombosis and Vascular Biology, 3(1).